| 101 |
24501149 | Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS. | 2014 Jul |
1 |
| 102 |
24505965 | [The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders]. | 2014 Jan |
2 |
| 103 |
24601829 | Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. | 2014 Jun |
2 |
| 104 |
24606639 | Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. | 2014 May |
2 |
| 105 |
24614687 | Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data. | 2014 Aug |
1 |
| 106 |
24876842 | The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance. | 2014 |
1 |
| 107 |
24898153 | Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. | 2014 Sep |
1 |
| 108 |
25010620 | Inositol: history of an effective therapy for Polycystic Ovary Syndrome. | 2014 Jul |
4 |
| 109 |
25042908 | The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. | 2014 Oct |
3 |
| 110 |
25054962 | [Myo-inositol in the treatment of polycystic ovary syndrome]. | 2014 Jun |
3 |
| 111 |
25245999 | Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause. | 2014 Oct |
1 |
| 112 |
25373012 | [Combination inositol and glucomannan in PCOS patients]. | 2014 Dec |
2 |
| 113 |
23336594 | Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. | 2013 Apr |
1 |
| 114 |
23412023 | [Evaluation of the myo-inositol-monacolin K association on hyperandrogenism and on the lipidic metabolism parameters in PCOS women]. | 2013 Feb |
2 |
| 115 |
23467955 | The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients. | 2013 Feb |
2 |
| 116 |
23596182 | The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity. | 2013 Sep |
3 |
| 117 |
23764390 | Potential role and therapeutic interests of myo-inositol in metabolic diseases. | 2013 Oct |
7 |
| 118 |
23981814 | Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial. | 2013 Aug 28 |
3 |
| 119 |
24219712 | Myoinositol: a new marker of intrauterine growth restriction? | 2013 Nov |
2 |
| 120 |
22192068 | One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. | 2012 Oct |
1 |
| 121 |
22587479 | CONCERN: Does ovary need D-chiro-inositol? | 2012 May 15 |
1 |
| 122 |
22592687 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2012 May 16 |
1 |
| 123 |
22612517 | Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. | 2012 Dec |
4 |
| 124 |
23232537 | [Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients]. | 2012 Dec |
1 |
| 125 |
20587749 | Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice. | 2011 Mar |
2 |
| 126 |
20811299 | Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. | 2011 Jan |
1 |
| 127 |
20814537 | Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes. | 2011 |
2 |
| 128 |
21300338 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. | 2011 Jun 30 |
2 |
| 129 |
21414183 | The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. | 2011 Aug |
5 |
| 130 |
21514580 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. | 2011 Jun 30 |
1 |
| 131 |
21845803 | Inositol safety: clinical evidences. | 2011 Aug |
1 |
| 132 |
22452173 | [Myoinositol--alternative treatment of insulin resistance in adolescents]. | 2011 |
3 |
| 133 |
20091537 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2010 Jan 20 |
1 |
| 134 |
20156067 | Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome. | 2010 Apr |
3 |
| 135 |
19059532 | Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity. | 2009 Jan |
1 |
| 136 |
19492925 | Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. | 2009 |
2 |
| 137 |
19499845 | Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. | 2009 Mar-Apr |
2 |
| 138 |
19551544 | Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. | 2009 Aug |
1 |
| 139 |
19800728 | Contribution of myo-inositol to reproduction. | 2009 Dec |
2 |
| 140 |
19821299 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2009 Oct 7 |
1 |
| 141 |
18335328 | Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. | 2008 Mar |
1 |
| 142 |
18375940 | Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. | 2008 Jun |
1 |
| 143 |
18609357 | Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension. | 2008 Aug |
1 |
| 144 |
18803944 | Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. | 2008 Oct |
3 |
| 145 |
18940392 | Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation. | 2008 Nov |
3 |
| 146 |
17116762 | Inositol phosphoglycan P-type in preeclampsia: a novel marker? | 2007 Jan |
1 |
| 147 |
17537518 | Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder? | 2007 Dec |
2 |
| 148 |
17664885 | Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. | 2007 |
1 |
| 149 |
17952759 | Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. | 2007 Dec |
2 |
| 150 |
16443877 | Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. | 2006 Feb |
1 |